HNN3.0
Register
Register
Register

Project cooperationUpdated on 16 January 2026

Seeking In Silico Modelling for Nanofiber-Based Cancer "Ecological Traps"

Strategy & Research Associate at Migration Biotherapeutics

Cambridge, United Kingdom

About

Migration Biotherapeutics is a UK-based start-up developing the ALIGHT device, a first-in-class "ecological trap" for Glioblastoma (GBM). Our technology utilises electrospun PCL nanofibers to physically redirect invasive tumour cells through contact guidance, preventing infiltration into healthy brain tissue.

For the HORIZON-MISS-2026-02-CANCER-01 call, we are seeking university-based research partners with expertise in in-silico computational modelling and Virtual Human Twin (VHT) development. We aim to create predictive digital models of our device’s physical steering mechanisms to accelerate R&D and provide performance data for First-in-Human trials. This collaboration will help validate the device's efficacy in a virtual environment, significantly de-risking the clinical translation process.

Similar opportunities

  • Project cooperation

    Seeking Computational & Organoid Partners to De-Risk Nanofiber-Based GBM R&D

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Enoch Alex

    Strategy & Research Associate at Migration Biotherapeutics

    Cambridge, United Kingdom

  • Project cooperation

    Partner Search: 3D Organoid Expertise for High-Fidelity GBM Device Validation

    Enoch Alex

    Strategy & Research Associate at Migration Biotherapeutics

    Cambridge, United Kingdom

  • Project cooperation

    Virtual Human Twin Models for Brain Tumour Progression Modelling & Personalised Treatment Response HORIZON-MISS-2026-02-CANCER-01

    Robertas Damaševičius

    Professor at Kaunas University of Technology

    Kaunas, Lithuania